{"name":"Orano Med LLC","slug":"orano-med-llc","ticker":"","exchange":"","domain":"oranomedllc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AlphaMedix","genericName":"AlphaMedix","slug":"alphamedix","indication":"Metastatic non-small cell lung cancer","status":"phase_2"}]}],"pipeline":[{"name":"AlphaMedix","genericName":"AlphaMedix","slug":"alphamedix","phase":"phase_2","mechanism":"AlphaMedix is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell proliferation.","indications":["Metastatic non-small cell lung cancer","Metastatic breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOMGJCOHJfYk9LWFBHY0p1X0JWeFNHOHBWaHdPQVZVS3BtTjJWeGZhUDY0SmlKZlJDM1ZPNDNqbFFpbWVlc3RlMzdhSS1FeG9BM2lJbjdXWEcyelh1WXIwU3VYeEt1TmRfNk9vN2J6SDJYNnl2b2htaFU1RzFUVHlVdURFZHlBUGpVRXE4ODhSN01rN0twUXBvcDdDOTlCWDVCYnZ0SFR3cDBaVl9UTDVoSnZMSW5hM2JZVndSb1c3a1NrcndzQXF3Qzl3?oc=5","date":"2026-04-08","type":"pipeline","source":"Business Wire","summary":"Orano Announces the Appointment of Frederic Desdouits as CEO of Orano Med - Business Wire","headline":"Orano Announces the Appointment of Frederic Desdouits as CEO of Orano Med","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOaUxDVmFjcmF4MmptQl9wMkJ4ZS1sQ0lVa0g4bEd3Smo0UkFyMnVhaXFzbkxvUHlJamZJd3dFejFIc3JtZTgxNlRJQ0Roc0VBSGVZNEt3S0ZOTklNMUl2V2dORWxCNnp4Xy1BTG1KekhDOThIbXFYblRpMXF1d1l2aW45QXktU2JSdGNaNTh4V2c5WDdncDk0bEc1OWxsQQ?oc=5","date":"2026-03-26","type":"pipeline","source":"openPR.com","summary":"Emerging Growth Patterns Driving Rapid Expansion in the Alpha Emitter Market - openPR.com","headline":"Emerging Growth Patterns Driving Rapid Expansion in the Alpha Emitter Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSzFveGMycWdvMXZmX0MyekF5WUlVTmg0eGljUlk5dmdFeHVYeTNpTFFMUmhPUXVVWmhOX2VVSTNCYXlxSkNsQ1NlWTAwV2pldXhreUN1SHNCNlhBUUljLTJHbmVYbzN2V2tKdDQwUDY0d2RtQ09CblhkYmRWU1VzbzdzRFNLbnNVeF85MldXS0N5Q2MydXYwWlFTUWowXzVGR1F1T0Rjcm9QX0RGWk9Gb1JQbXY?oc=5","date":"2025-10-08","type":"trial","source":"Fierce Biotech","summary":"Sanofi's $110M radioligand therapy hits response rate goal in phase 2 tumor trial - Fierce Biotech","headline":"Sanofi's $110M radioligand therapy hits response rate goal in phase 2 tumor trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPTmVHeWZWbDcwMFFqZUZzZlNaZFpYdGNCbldZczFISUNLYXNwVTB5M24wLXdleGNaMDZXWE4tc3BiSjZfb1N1Y2VtT0Rxdlp3S3ZGOHhzOG9QNG1wN1VHVmx3bUk3QVNPUncta2thZUtSOUpZTmtUb3ZnVlpEV2V0c0k4cl9maGFVbVdPc291V1hRQjVGSTBOd3NxYlJwMlpHc09fTzFDV0dsZ1ZmVHd2Rl84S0dyYVpYZ1gtYlZ1RXlmbUwxa3E4anJuVjhkTHBJSW8ydGlyRk9EMXZZbWtVaXBjbWVuSHVrZ1lxbDViTC0wa0FwZ2RsekRibDhydUk4TTl4MUdMN1ViMWctWk5pVnJJZ0RhZTR5?oc=5","date":"2024-11-25","type":"pipeline","source":"globenewswire.com","summary":"Neuroendocrine Tumors Market to Showcase Rapid Growth - globenewswire.com","headline":"Neuroendocrine Tumors Market to Showcase Rapid Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNSmpFdkVCaTV4M0x6cnRHaWtlcnBQUEExX1l4SWpfVzBDaUoxZVROYTNHbmlZbkdZQVVBSFJwYVA3R3czNmFWc200VGdoOGdZWWRENkNUQWl1dmswMnlRUndoZ0ZUWWdUQ0xkU25YRFVyT0ZyNG5LRWVDdXZaNDFfQXNjdG52aTNubEN4REs2V1Q2OEkySzBPdVpyT2tpSXlCTkNIQTktd205YlE3SFlMYXlBcFBJazFqb0tkZmxTTE1SdFk1?oc=5","date":"2024-11-15","type":"pipeline","source":"Fierce Pharma","summary":"After US plant reveal, France's Orano Med lays out €250M to build another radioligand facility overseas - Fierce Pharma","headline":"After US plant reveal, France's Orano Med lays out €250M to build another radioligand facility overseas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNUHRORFhHWkNCTFFLc3RrQm5IUlhaU19QTHNyN0NKWExQZGRFRk9vaHFleTR1M19CZnU0RkZPR1JhaG9nc1czSkUySHlpLTVDaUdDa2hkUy11U2V0TXJpMmFSZHBPR3FWZVpPQ3UzVzN1OFA5VVBZVFlYNG5sRlhPYVYwTk84MkpQQ2M4c3Y2cDJZNkRPamg0OHhGTGgtOVVfanNZQVExVWk2UzRUN2FOalNXWTVfNkFjNlBHTWJDMEU1UQ?oc=5","date":"2024-10-22","type":"pipeline","source":"Fierce Pharma","summary":"Telix unveils radiopharmaceutical spinoff Rhine Pharma following string of nuclear medicine acquisitions - Fierce Pharma","headline":"Telix unveils radiopharmaceutical spinoff Rhine Pharma following string of nuclear medicine acquisitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPbU4xcmEtdl9qd3lVb1BqRkU2Y3ZpQ19EY2pzZUFWMjIwS1l1T3lWUHgtazBfRmdLV0F5Zkg2N09heEhiS0hxaVlwb0NtV2plMmJ3U0UxVXlGajc3bWtUY0JNeDNuYWpBaHVJbUg1NDI0SFlfODBmbHB4YmljYUZKMno2clpzdUVmTmJWY1dtZms5LUU?oc=5","date":"2024-10-17","type":"pipeline","source":"Fierce Biotech","summary":"Sanofi returns to Orano with €300M for radioligand 'pioneer' project - Fierce Biotech","headline":"Sanofi returns to Orano with €300M for radioligand 'pioneer' project","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPdTEwRnVOTVl3bVZKeVh4NE9kYjZsQ3NWeFJydVlLd0dDVnZMbWh2d3FHbkdwNmt3R3dVSEhla0ZDN3F2SEpmcWQwT2dqbUpCaUFHbEU2NlZKSXBGVmFXLURoZ1FIb1dWcmZJa1o1RFRSRUdMUUZBMmFkbmpDN1B3N3F0ZUpyZk5fazRqTEtNZXhqcWFEckE5eUhhWVdVSUdDZldkcEp0RV9MM3R0cVpFME1LOFV0bUNJWlE?oc=5","date":"2024-09-12","type":"pipeline","source":"Fierce Biotech","summary":"Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis - Fierce Biotech","headline":"Sanofi pays $110M upfront for late-stage radioligand therapy, setting up rivalry with Novartis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9LcVM5NXFjdUZZdjR4NVRONjZWYnNjSUNoRC1OaFJFVGRVUVJmVHc3dW9TYXZUQVhnLTY4WnJRVk5ZODZJRlpWSldyUDQwdmhlbkU3WXpKS0hkdHVKM29aTlJYajhQN3M3d3ZzcWNXV1J6bTlseFQ0?oc=5","date":"2024-07-23","type":"pipeline","source":"BioCentury","summary":"Lead-212’s leading players - BioCentury","headline":"Lead-212’s leading players","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPN0hNQkNaSE5SbGtYTDRNbmY4OWV3ODJlb1ZFZW1jWW5zSklGWEtDOS1mYUJFUHdWMGxyLTN2ZDR4aFB2c0tLNnFRQ2lZTGJ6aGViRWRWT0lPRVctLVBGYzEzdFU5RTFsLWtoUW1CU2ZqUkMzQnFNVTk3bmxZZWhCQnhaMW1wdkhrSENYWC1VaUQ2a1V1NW1CYWJMbmhpUU1TenY3NjVRWW5JZUF3d25WaDZKZmhQMVN2UjF6RTluaUY4dVJGelo3N2huRlJ2b1BKRHpIVXltc3dLODNPNkt0bGN3RGg4WGdtTjU4QUdDNm9rTGhtVVd3SjB1QzdPemNKbXMzV3pSN19handVUjgzN0laVVpQNFF2N2p4dWtvcE8zd01hZmJzekZvMDA4YkVjNFlB?oc=5","date":"2024-07-09","type":"pipeline","source":"PR Newswire","summary":"Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key Companies - Curium US, Eli Lilly, Point Biopharma, Fusion, Astrazeneca - PR Newswire","headline":"Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight | Key Companies - Curium US, Eli Lill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOYjRROUtqWTVNdVRnZEFJLVZmUnhVa3RFSzV3WGhZNUdRNjVPUUhNOU12TE5NaXVCdmFxWjVzRDVFbF9SQ2VVZkpXMDkySXFWbUs3bno2bzkyd2FYMXg4NzJ0OXZpQTRONXdOSHZOUWRLemxndm1CX09DdFJyNDhUa29aR0tIOEJJcWhuX0RRR1hJdGRJN2tlbjF6LVdiU0N5WVJQbTUxaEpFdw?oc=5","date":"2024-06-06","type":"pipeline","source":"Fierce Pharma","summary":"France's Orano Med debuts radiotherapy manufacturing plant near Indianapolis - Fierce Pharma","headline":"France's Orano Med debuts radiotherapy manufacturing plant near Indianapolis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBKcjBlS1N1bDZkY3lNZmI4QTEwM0p2cHl2bGRvajFFZzM3MVprUE04VWFLdW5VQXFOMnowUGwwUHBsWTdaTnVaenE2cm1wSWE1X1NCdGY2ZGhGZTJCRmRNYWpFakQxZw?oc=5","date":"2023-03-21","type":"pipeline","source":"Straits Research","summary":"Alpha Emitter Market Size, Share & Growth Graph by 2034 - Straits Research","headline":"Alpha Emitter Market Size, Share & Growth Graph by 2034","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}